entertainment -WSS

entertainment

author：hotspot 2025-08-10 11:42:31 - browse：2

Illustration of a human hand beneath a projection of digital files to visualize humans' role in AI technology — Adobe

Developers of artificial intelligence models slowly making their way into medicine have long parried ethical concerns with assertions that clinical staff must review tech’s suggestions before they are acted on. That “human in the loop” is meant to be a backstop preventing potential medical errors conjured up by a flawed algorithm from harming patients.

And yet, industry experts warn that there’s no standard way to keep humans in the loop, giving technology vendors significant latitude to market their AI-powered products as helpful professional tools rather than as autonomous decision-makers.

Health record giant Epic is piloting a generative AI feature that drafts responses to patients’ email queries, but clinical staff must review the suggestions before they are sent out, the company has said. A flurry of AI-guided ambient documentation startups can rapidly transcribe and summarize patient visits and populate patients’ medical charts, but they require doctors and nurses to OK the generated entries first. Products predicting health risks — like overdose or sepsis — show up as flags in medical record software, and it’s up to clinicians to act on it.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： In age of alternative facts, a scholarly course on calling out crap
Next article： STAT Summit: How a Chicago ER doctor tackles gun violence

WSS

Studies point to risks of excluding people with obesity from drug trials

FDA warns J&J's Abiomed: We will regulate your software

Medicare inequities exacerbate Puerto Rico’s health disparities

Senate committee scrutinizes Medicare Advantage brokers

PBM reform efforts get punted in Congress

Alabama IVF ruling threatens families facing fatal genetic disease

Wikipedia

entertainment

leisure time

Tori Bowie and the unacceptable rates of Black maternal death

STAT Summit: Biotech founders on deal

Cancer drug shortages should be causing more outrage

R1 RCM gets $5.8 billion buyout offer from private equity firm

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Ocular Therapeutix moves raise hopes, and Alnylam tries to calm some nerves

Cancer drug shortages should be causing more outrage

Readout Newsletter: Alnylam, Celldex, Roche, Zealand Pharma

Medicare details structure of new drug price negotiation program

Obesity drugs seen as possible treatment for liver disease MASH

hotspot

STAT Summit: Michael J. Fox on progress in Parkinson's research

In utero gene editing: an explainer

PBM reform efforts get punted in Congress

R1 RCM gets $5.8 billion buyout offer from private equity firm

UnitedHealth’s board chair also owns a personal investment firm

6 phony surgeries that take placebo to the extreme

entertainment

Wikipedia

hotspot

knowledge